JW (Cayman) Therapeutics Co. Ltd.'s market cap is currently HK$1.00B. The company's EPS TTM is HK$-1.673; its P/E ratio is ―; JW (Cayman) Therapeutics Co. Ltd. is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 173.86M	¥ 145.70M	¥ 30.80M	¥ 0.00	¥ 5.48M
Gross Profit	¥ 88.22M	¥ 58.76M	¥ 9.04M	¥ 0.00	¥ 5.48M
Operating Income	¥ -789.61M	¥ -697.17M	¥ -771.72M	¥ -467.86M	¥ -203.52M
EBITDA	¥ -655.75M	¥ -752.27M	¥ -738.70M	¥ -454.04M	¥ -194.40M
Net Income	¥ -768.00M	¥ -846.13M	¥ -702.33M	¥ -1.66B	¥ -633.26M
Balance Sheet
Cash & Short-Term Investments	¥ 1.01B	¥ 1.39B	¥ 1.84B	¥ 2.63B	¥ 254.95M
Total Assets	¥ 2.15B	¥ 2.79B	¥ 3.12B	¥ 3.78B	¥ 668.62M
Total Debt	¥ 318.80M	¥ 279.13M	¥ 147.03M	¥ 123.59M	¥ 77.78M
Net Debt	¥ -687.11M	¥ -1.10B	¥ -1.69B	¥ -2.51B	¥ -177.08M
Total Liabilities	¥ 462.26M	¥ 437.06M	¥ 325.75M	¥ 349.76M	¥ 1.61B
Stockholders' Equity	¥ 1.68B	¥ 2.35B	¥ 2.79B	¥ 3.43B	¥ -942.34M
Cash Flow
Free Cash Flow	¥ -413.00M	¥ -613.60M	¥ -634.28M	¥ -385.24M	¥ -290.87M
Operating Cash Flow	¥ -398.42M	¥ -536.72M	¥ -561.20M	¥ -261.00M	¥ -188.92M
Investing Cash Flow	¥ 9.90M	¥ -124.08M	¥ -137.13M	¥ -91.91M	¥ -117.55M
Financing Cash Flow	¥ 275.00K	¥ 112.35M	¥ -30.62M	¥ 2.86B	¥ 414.05M

Currency in CNY

JW (Cayman) Therapeutics Co. Ltd. Earnings and Revenue History

Income Statement >

JW (Cayman) Therapeutics Co. Ltd. Debt to Assets

Balance Sheet >

JW (Cayman) Therapeutics Co. Ltd. Cash Flow

Cash Flow >

JW (Cayman) Therapeutics Co. Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing